Trademark Search in Canada

KYGEVVI

View On IC.GC.CA

REGISTERED

on 24 May 2024

Last Applicant/ Owned by

UCB BIOSCIENCES INC.

4000 Paramount Parkway,Suite 200Morrisville NC 27560

Serial Number

2222785 filed on 23^rd Sept 2022

Registration Number

TMA1235301 registered on 24^th May 2024

Registration expiry Date

11^th Apr 2032

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

KYGEVVI

Trademark usage description

pharmaceuticals; pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, Read More

Classification Information

Class [005]
Pharmaceuticals; pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders.

Classification kind code

Mark Details

Serial Number

2222785

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 12^th Feb 2024	Approval Notice Sent
Submitted for opposition 22 on 6^th Feb 2024	Search Recorded
Submitted for opposition 67 on 15^th Dec 2023	Agent Name Changed
Submitted for opposition 256 on 18^th Sept 2023	Notification of Possible Opposition Sent
Submitted for opposition 48 on 29^th Dec 2022	Agent Changed
Submitted for opposition 257 on 17^th Nov 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 16^th Nov 2022	Formalized
Submitted for opposition 1 on 16^th Nov 2022	Created
Submitted for opposition 30 on 23^rd Sept 2022	Filed
Submitted for opposition 228 on 11^th Apr 2022	International Registration

KYGEVVI

Classification Information

Class [005]Pharmaceuticals; pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals; pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders.